References
- Maymone MBC, Laughter M, Venkatesh S, et al. Leprosy: clinical aspects and diagnostic techniques. J Am Acad Dermatol. 2020;83(1):1–14. doi:10.1016/j.jaad.2019.12.080
- Maymone MBC, Venkatesh S, Laughter M, et al. Leprosy: treatment and management of complications. J Am Acad Dermatol. 2020;83(1):17–30. doi:10.1016/j.jaad.2019.10.138
- Makhakhe L. Leprosy review. S Afr Fam Pract. 2021;63(1):e1–e6. doi:10.4102/safp.v63i1.5311
- Khadilkar SV, Patil SB, Shetty VP. Neuropathies of leprosy. J Neurol Sci. 2021;420:117288. doi:10.1016/j.jns.2020.117288
- Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966;34(3):255–273.
- Mi Z, Liu H, Zhang F. Advances in the Immunology and Genetics of Leprosy. Front Immunol. 2020;11:567. doi:10.3389/fimmu.2020.00567
- Randhawa A, Kapila R, Schwartz RA. Leprosy: what is new. Int J Dermatol. 2022;61(6):733–738. doi:10.1111/ijd.15998
- Ebenezer GJ, Scollard DM. Treatment and evaluation advances in leprosy neuropathy. Neurotherapeutics. 2021;18(4):2337–2350. doi:10.1007/s13311-021-01153-z
- Froes LARJ, Sotto MN, Trindade MAB. Leprosy: clinical and immunopathological characteristics. An Bras Dermatol. 2022;97(3):338–347. doi:10.1016/j.abd.2021.08.006
- Palit A, Kar HK. Prevention of transmission of leprosy: the current scenario. Indian J Dermatol Venereol Leprol. 2020;86(2):115–123. doi:10.4103/ijdvl.IJDVL_326_19
- Jesus ILR, Montagner MI, Montagner M, Alves SMC, Delduque MC. Hanseníase e vulnerabilidade: uma revisão de escopo [Leprosy and vulnerability: a scoping review]. Cien Saude Colet. 2023;28(1):143–154. Portuguese. doi:10.1590/1413-81232023281.09722022
- Sarode G, Sarode S, Anand R, et al. Epidemiological aspects of leprosy. Dis Mon. 2020;66(7):100899. doi:10.1016/j.disamonth.2019.100899
- Fava VM, Dallmann-Sauer M, Schurr E. Genetics of leprosy: today and beyond. Hum Genet. 2020;139(6–7):835–846. doi:10.1007/s00439-019-02087-5
- Avanzi C, Singh P, Truman RW, Suffys PN. Molecular epidemiology of leprosy: an update. Infect Genet Evol. 2020;86:104581. doi:10.1016/j.meegid.2020.104581
- Neema S, Battula S. Lepromatous Leprosy. N Engl J Med. 2022;387(13):1217. doi:10.1056/NEJMicm2202533
- Deps P, Cruz A. Why we should stop using the word leprosy. Lancet Infect Dis. 2020;20(4):e75–e78. doi:10.1016/S1473-3099(20)30061-X
- Froes LAR Jr, Trindade MAB, Sotto MN. Immunology of leprosy. Int Rev Immunol. 2022;41(2):72–83. doi:10.1080/08830185.2020.1851370
- Houghton F, Winterburn M. Leprosy in Nepal: a re-emerging threat. J Public Health Policy. 2021;42(1):176–181. doi:10.1057/s41271-020-00260-z
- Mushtaq S. Leprosy in the post-elimination phase: so near and yet so far. G Ital Dermatol Venereol. 2020;155(3):269–279. doi:10.23736/S0392-0488.19.06249-7
- Bala Murugan S, Mahendradas P, Dutta Majumder P, Kamath Y. Ocular leprosy: from bench to bedside. Curr Opin Ophthalmol. 2020;31(6):514–520. doi:10.1097/ICU.0000000000000715
- Gómez-Cerquera JM, Herrera-Darias S, Domingo-Amela A, Graells-Estrada J. Lepromatous leprosy. Med Clin. 2022;159(11):556. doi:10.1016/j.medcli.2022.07.015